Apheris Foundry

Apheris AI GmbH is a Berlin-based company (address in its privacy policy) that builds a platform for running AI on sensitive life-science data inside the data owner's environment. The founding year is not stated on the pages reviewed. A law firm notice dated 2025-01 reports an 8.25 million USD Series A, bringing total funding to 20.8 million USD.

Apheris Foundry deploys models in the customer's environment and continuously customizes them on the customer's own data, embedding them in drug-program workflows. It is model-agnostic. The company runs networks for AI structural biology, ADMET, antibody developability, real-world evidence and virtual cell, and offers ApherisFold for co-folding predictions in the browser.

• Foundry deployment: Runs inside the customer's environment.
• Continuous customization: Adapts models to the customer's own data.
• Workflow embedding: Integrates models into drug-program workflows.
• Model-agnostic: Supports open-source or customer-built models.
• Collaborative networks: AI structural biology, ADMET, antibody, RWE and virtual cell.
• ApherisFold: Co-folding predictions delivered in the browser.

Research hospitals can contribute to joint models without moving patient data. Pharma R&D teams can customize prediction models on proprietary assay data. Biotech consortia can benchmark models across members.

Data stays inside the owner's environment while models are customized on it. Model-agnostic, so teams can use open-source or in-house models. Participation in shared networks lets pharma teams benefit from broader evaluation. A Trust Center publishes compliance and audit reports.

Pharma and biotech want to use proprietary data for AI without exposing it, which favors federated and in-place approaches. Vietnamese pharma, hospital and research groups with sensitive clinical data may adopt similar secure collaboration models.

apheris AI GmbH, Berlin. Series A of 8.25 million USD reported 2025-01 (law firm notice); total funding 20.8 million USD; led by OTB Ventures and eCAPITAL with Octopus Ventures and Heal.Capital. Partners: AWS, SandboxAQ, TriNetX.